ARTVIGIL – potency product | Buy in Ukraine with delivery

What is ARTVIGIL?

ARTVIGIL is a modern medicinal drug belonging to the pharmacological group of psychostimulants and nootropics. The main purpose of the drug is the correction of conditions associated with increased daytime sleepiness, sleep-wake cycle disorders, and reduced cognitive performance. The drug is produced in the form of tablets for oral administration, ensuring convenient dosage and high bioavailability of the active substance. The manufacturer of ARTVIGIL ensures strict quality control at all stages of production in accordance with international standards of Good Manufacturing Practice. Thanks to a balanced composition and a predictable pharmacokinetic profile, the drug has earned the trust of specialists in the fields of neurology and somnology.

ARTVIGIL belongs to the category of prescription drugs, emphasizing the need for medical supervision during its use. The mechanism of action of the drug is associated with its effect on the dopaminergic and noradrenergic systems of the brain, providing a pronounced wakefulness-promoting effect without excessive stimulation of the peripheral nervous system. Unlike classic amphetamine-type psychostimulants, ARTVIGIL has a significantly lower potential for addiction development and less pronounced sympathomimetic effects. The drug is well tolerated by most patients provided that the recommended doses and administration regimen are observed. Clinical studies confirm the effectiveness of ARTVIGIL in improving wakefulness, concentration, and overall cognitive function.

The pharmacokinetic properties of ARTVIGIL are characterized by rapid absorption in the gastrointestinal tract and reaching peak plasma concentrations approximately two to three hours after administration. The elimination half-life of the active substance is about 12–15 hours, allowing the drug to be used once daily. Metabolism occurs primarily in the liver with the participation of cytochrome P450, which should be taken into account when co-prescribed with other medications. Excretion of metabolites is carried out mainly by the kidneys, so patients with impaired renal function may require dose adjustment. ARTVIGIL provides a stable therapeutic effect throughout the entire period of active wakefulness.

What is ARTVIGIL prescribed for?

The main indications for the use of ARTVIGIL are conditions accompanied by pathological daytime sleepiness and sleep cycle disorders. The drug is prescribed to patients diagnosed with narcolepsy — a chronic neurological disorder in which the brain is unable to properly regulate sleep and wake cycles. In narcolepsy, ARTVIGIL helps reduce the frequency of uncontrolled daytime falling-asleep episodes and improve the overall quality of life of the patient. The drug is also effective in obstructive sleep apnea syndrome as an adjunct to primary continuous positive airway pressure therapy. In such cases, ARTVIGIL eliminates residual daytime sleepiness that persists even after the correction of nocturnal breathing.

ARTVIGIL is widely used for shift work sleep disorders, when professional activity requires alertness at night or during frequent changes of time zones. The drug helps adapt the body to an unconventional wakefulness schedule, reducing feelings of fatigue and improving concentration during periods when the biological clock signals the need for sleep. ARTVIGIL is of particular value to emergency service workers, medical personnel, long-distance drivers, and other professionals whose work involves increased alertness requirements. In such situations, the drug allows maintaining a high level of cognitive function and reaction speed without harming health.

An additional indication for the use of ARTVIGIL is idiopathic hypersomnia — a condition in which the patient experiences constant sleepiness without an apparent organic cause. The drug may also be recommended in the complex therapy of depressive states accompanied by pronounced asthenia and reduced energy potential. In some cases, doctors prescribe ARTVIGIL for chronic fatigue syndrome when standard correction methods do not produce a sufficient effect. It is important to understand that the drug does not replace full sleep, but only helps the body function under conditions of its deficiency or impaired regulation. The prescription of ARTVIGIL should always be based on a thorough examination and establishing an accurate diagnosis.

Composition and active ingredients of ARTVIGIL

The active ingredient of ARTVIGIL is armodafinil — an enantiomerically pure form of modafinil that provides a longer and more stable therapeutic effect. Armodafinil belongs to the class of wakefulness-promoting drugs and acts by increasing extracellular levels of dopamine in the brain by blocking its reuptake. Unlike racemic modafinil, armodafinil has a longer elimination half-life, which allows maintaining a therapeutic concentration throughout the day with a single dose. The mechanism of action also includes modulation of the activity of hypothalamic neurons responsible for regulating the sleep-wake cycle. This approach provides a natural feeling of vigor without pronounced psychomotor agitation.

The excipients of ARTVIGIL are selected to ensure optimal release rates of the active substance and drug stability throughout its shelf life. The tablet composition includes microcrystalline cellulose, lactose monohydrate, pregelatinized starch, povidone, magnesium stearate, and other pharmaceutically acceptable fillers. Each excipient performs a specific function: some provide the mechanical strength of the tablet, others contribute to uniform disintegration in the gastrointestinal tract. Patients with lactose intolerance should consider its presence in the composition of the drug and inform their doctor about it. The manufacturer guarantees the absence of impurities exceeding permissible pharmacopoeial standards.

The therapeutic effect of ARTVIGIL is realized through a complex effect on the neurotransmitter systems of the brain, in particular on dopamine, noradrenaline, and histamine. Increased dopamine levels in the prefrontal cortex improve cognitive functions, working memory, and planning ability. Activation of the noradrenergic system contributes to an increase in the overall level of alertness and reaction speed to external stimuli. The effect on histamine receptors in the hypothalamus ensures stable maintenance of a wakeful state without a feeling of excessive stimulation. Such a multicomponent mechanism of action favorably distinguishes ARTVIGIL from traditional stimulants that act primarily through a single neurotransmitter system.

Dosage of ARTVIGIL

The standard recommended dose of ARTVIGIL for adult patients is 150 mg once daily, preferably in the morning or one to two hours before the start of a work shift. For patients with narcolepsy and obstructive sleep apnea syndrome, this dose is optimal for maintaining alertness throughout the day. In case of an insufficient clinical response, a doctor may consider increasing the dose to 250 mg per day; however, such a decision is made individually after evaluating the tolerability of the drug. Exceeding the maximum daily dose is not recommended due to an increased risk of side effects without a proportional increase in therapeutic benefit. The duration of the course of treatment is determined by the nature of the underlying disease and can range from several weeks to prolonged use under medical supervision.

For patients with shift work sleep disorder, ARTVIGIL is prescribed at a dose of 150 mg approximately one hour before the start of a night shift. This regimen allows reaching the peak concentration of the drug precisely during the period when the body needs alertness support the most. Elderly patients may require dose adjustment taking into account age-related declines in liver and kidney function, which affect the rate of metabolism and excretion of the drug. In such cases, the initial dose may be reduced to 100 mg per day with subsequent titration under the control of clinical response. It is important not to change the dosage on your own without consulting a doctor, as this may lead to insufficient efficacy or the development of adverse reactions.

In cases of severe liver function impairment, the dose of ARTVIGIL should be reduced to half the standard dose, as the metabolism of the drug slows down significantly. Patients with renal insufficiency usually do not require dose adjustment; however, careful monitoring of the patient's condition is recommended. A missed regular dose should not be compensated for by taking a double dose next time, as this increases the risk of overdose and side effects. The maximum duration of continuous use of ARTVIGIL is not limited, but requires periodic assessment of the benefit-risk ratio by a doctor. The drug is not intended for use in pediatric practice due to a lack of sufficient data on safety and efficacy in this age group.

How to take ARTVIGIL correctly?

ARTVIGIL should be taken orally with a sufficient amount of water, regardless of food intake. However, it should be noted that taking the drug with fatty food can delay its absorption and postpone the onset of the therapeutic effect by approximately one to two hours. To achieve maximum efficacy, it is recommended to take the tablet at the same time every day, which helps form a stable concentration of the active substance in the body. Patients working night shifts should take ARTVIGIL one hour before starting work, rather than after completing it. This approach ensures the maintenance of alertness precisely during the period when it is necessary for performing professional duties.

If a regular dose of ARTVIGIL is missed, it should be taken as soon as possible if more than six hours remain before the next scheduled dose. If the time for the next dose is already close, the missed dose should be skipped and you should return to the normal schedule to avoid excessive drug concentration in the blood. It is strictly not recommended to take ARTVIGIL in the afternoon or evening for patients with a standard sleep pattern, as this may cause difficulty falling asleep and disrupt the natural circadian rhythm. During treatment, it is important to adhere to a regular sleep regimen, providing the body with sufficient time to recover. The drug is not a substitute for complete sleep, but only a tool for correcting its disorders in certain clinical situations.

Before starting ARTVIGIL, the patient must undergo a full medical examination to rule out cardiovascular diseases, psychiatric disorders, and other conditions that may be contraindications. The doctor must evaluate baseline blood pressure, heart rate, and perform an electrocardiographic examination. During long-term use of the drug, periodic monitoring of these indicators is recommended, especially in patients with existing risk factors. The individual response of the body to ARTVIGIL may vary depending on age, sex, genetic characteristics of metabolism, and concomitant diseases. Therefore, any changes in health status during treatment should be discussed with a doctor for timely adjustment of therapy.

Side effects of ARTVIGIL

The most common side effect of ARTVIGIL is headache, which occurs in approximately one in five patients at the start of treatment and usually decreases over time. Also common are nausea, dry mouth, decreased appetite, and sleep disturbance, especially when taking the drug late in the day. Some patients report increased anxiety, irritability, or a sense of inner tension, which usually passes after the body adapts to the drug. These symptoms are generally mild to moderate in nature and do not require discontinuation of treatment. To reduce the severity of headaches, it is recommended to ensure an adequate fluid intake and avoid excessive consumption of caffeinated beverages.

Uncommon adverse reactions of ARTVIGIL include tachycardia, increased blood pressure, palpitations, and chest discomfort. Patients with cardiovascular disease should be particularly attentive to such symptoms and report them to a doctor immediately. Rare but serious side effects are severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, which require immediate discontinuation of the drug and medical attention. Cases of psychiatric disorders such as hallucinations, manic states, and suicidal ideation have also been described, requiring careful monitoring of the patient's mental state. The appearance of any unusual symptoms is a reason to consult a doctor.

The body's individual response to ARTVIGIL can vary significantly, so it is impossible to predict exactly which side effects will occur in a particular patient. Some people tolerate the drug without any adverse effects, while others may experience marked discomfort even at minimal doses. In the event of allergic reactions, such as rash, itching, facial swelling, or difficulty breathing, you should immediately stop taking the drug and seek emergency medical attention. It is important to understand that most side effects are dose-dependent and decrease with dose adjustment by a doctor. Unauthorized dose increases to enhance the effect significantly increase the risk of serious adverse reactions.

Contraindications of ARTVIGIL

Absolute contraindications to the use of ARTVIGIL are hypersensitivity to armodafinil, modafinil, or any excipient of the drug. The drug is not prescribed to patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, recent myocardial infarction, unstable angina, and severe heart rhythm disorders. The presence of psychotic disorders, bipolar affective disorder, or severe depression with psychotic symptoms is also a contraindication due to the risk of exacerbating psychiatric symptoms. In patients with left ventricular hypertrophy and mitral valve prolapse, the drug is prescribed with extreme caution after a thorough assessment of the benefit-risk ratio. Age under 18 years is a contraindication due to the lack of sufficient safety data in this population.

Pregnancy is a contraindication to the use of ARTVIGIL, as animal studies have shown a potential risk to fetal development. Women of childbearing potential are recommended to use reliable methods of contraception during treatment and for one month after its completion. The breastfeeding period is also a contraindication, as it is unknown whether armodafinil passes into breast milk. In patients with severe hepatic impairment, the drug is prescribed only in cases of extreme necessity with an appropriate dose reduction. A history of drug abuse or a tendency to misuse psychoactive substances requires special caution when prescribing ARTVIGIL.

Relative contraindications are moderate arterial hypertension, mild to moderate hepatic impairment, and the presence of anxiety disorders. In elderly patients, the drug is prescribed with caution, starting with minimal effective doses and carefully monitoring the state of the cardiovascular system. In persons with a history of epilepsy, ARTVIGIL can be prescribed only if seizure activity is adequately controlled by antiepileptic drugs. Before starting treatment, the doctor must take a complete medical history, including information about all concomitant diseases and medications taken by the patient. Only a comprehensive assessment of health status allows making an informed decision on the appropriateness of ARTVIGIL in each specific case.

Interaction of ARTVIGIL with other drugs and alcohol

ARTVIGIL can interact with a number of medicinal products, altering their efficacy or increasing the risk of adverse reactions. The drug is a moderate inducer of the CYP3A4 cytochrome P450 enzyme, so it can accelerate the metabolism of hormonal contraceptives, reducing their reliability throughout the treatment period and for one month after its completion. Women taking ARTVIGIL are recommended to use additional or alternative methods of contraception. Concomitant use with warfarin and other anticoagulants requires regular monitoring of blood clotting parameters, as a decrease in their anticoagulant effect is possible. Patients taking antiepileptic drugs, antidepressants, or anxiolytics should inform their doctor before starting therapy with ARTVIGIL.

Alcohol consumption during treatment with ARTVIGIL is strictly not recommended, as this can lead to unpredictable reactions from the central nervous system. Alcohol can both enhance and mask the effects of the drug, creating a false sense of sobriety and increasing the risk of dangerous behavior. In addition, combining alcohol with ARTVIGIL increases the load on the liver and can cause severe intoxication. The drug may affect the ability to drive vehicles and work with machinery, especially at the start of treatment or when changing doses. Patients should refrain from driving until they are sure of the absence of a negative impact of the drug on their reaction time and coordination.

Where to buy ARTVIGIL in Ukraine

ARTVIGIL is available in pharmacy chains in Ukraine exclusively by prescription, which guarantees controlled and safe use of the drug. Purchasing the drug is possible both in physical pharmacies and through licensed online medication booking services, which significantly simplifies the process for patients. Before placing an order, it is necessary to make sure that a valid prescription from a doctor is available, as dispensing the drug without it is prohibited by the legislation of Ukraine. The cost of ARTVIGIL may vary depending on the pharmacy chain, region, and current market situation, so it is recommended to compare prices from different sources. Patients should beware of offers to purchase the drug without a prescription, as this may indicate a counterfeit product.

Storage conditions for ARTVIGIL require keeping the drug in its original packaging at a temperature not exceeding 25 degrees Celsius in a place protected from light and moisture. The drug should be stored out of reach of children, as accidental ingestion can have serious consequences for a child's body. The shelf life is usually two to three years from the date of manufacture, after which use of the drug is strictly prohibited. Many pharmacy chains offer home delivery services for medicines, which is especially convenient for patients with limited mobility or those living in remote settlements. Before starting to take ARTVIGIL, it is mandatory to consult a doctor, as self-medication can be dangerous to the patient's health and life.